Expanding trial of SELICA III to Canada, for children with UCD

Lately the Canadian health authority has given the Cytonet approval to extend the trial of SELICA III that began first in United States of America in 2010 and now it will be extended to Canada, the main aim of this trial is to make an evaluation concerning the safety and efficiency of liver cell therapy [...]